Daiichi Sankyo’s takeover of ‘Effient’ license

Daiichi Sankyo Korea(CEO Dae-joon Kim) announced a transfer of the product right of an oral antiplatelet agent, ‘Effient(generic name: prasugrel),’ from Lilly Korea as of the 13^th of July.

Daiichi Sankyo Korea and Lilly Korea has jointly promoted Effient in Korea since October 2010, and Daiichi Sankyo Korea has solely conducted the Effient’s sale and marketing activities under the agreement be...